The coronary no-reflow phenomenon: a review of mechanisms and therapies.
about
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionAdenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionVasodilators in the treatment of patients with acute myocardial infarction undergoing percutaneous coronary interventionNo reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarctionNo-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial InfarctionDifferent effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.Microvascular obstruction assessed by 3-tesla magnetic resonance imaging in acute myocardial infarction is correlated with plasma troponin I levels.Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction.A rotational ablation tool for calcified atherosclerotic plaque removal.Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.Non-invasive evaluation of myocardial reperfusion by transthoracic Doppler echocardiography and single-photon emission computed tomography in patients with anterior acute myocardial infarction.Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective studyThe no-reflow phenomenon in coronary arteries.Altered serum creatine kinase level and cardiac function in ischemia-reperfusion injury during percutaneous coronary intervention.Management of 'no-reflow' complicating reperfusion therapy.Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary interventionPrevention and treatment of no-reflow.New strategies for the management of no-reflow after primary percutaneous coronary intervention.Treating thrombus in the coronary arteries.Manual Aspiration Thrombectomy in Acute Myocardial Infarction: A Clinical Experience.Assessing Coronary Blood Flow Physiology in the Cardiac Catheterisation Laboratory.Complications of coronary intervention: device embolisation, no-reflow, air embolism.Intracoronary adenosine versus intravenous adenosine during primary PCI for ST-elevation myocardial infarction: which one offers better outcomes in terms of microvascular obstruction?[Thrombus aspiration in patients with acute myocardial infarction : Scientific evidence and guideline recommendations].The Relation Between No-Reflow Phenomenon and Complete Blood Count Parameters.Aspiration thrombectomy and intracoronary tirofiban in ST-segment elevation myocardial infarction : Combination treatment for patients undergoing primary percutaneous coronary intervention.MRI manifestations of persistent microvascular obstruction and acute left ventricular remodeling in an experimental reperfused myocardial infarctionDistal administration of very high doses of intracoronary adenosine for the treatment of resistant no-reflowExperience and Outcomes of Primary Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction of Tertiary Care Center in Bosnia and Herzegovina.Clinical risk scores predict procedural complications of primary percutaneous coronary intervention.Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarctionThe role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.Aspiration thrombectomy and primary percutaneous coronary intervention.The significance of microthrombosis and fgl2 in no-reflow phenomenon of rats with acute myocardial ischemia/reperfusion.Effects of percutaneous coronary thrombectomy with the X-sizer catheter on epicardial flow and microvascular function in acute coronary syndromes.The role of SCUBE1 in the pathogenesis of no-reflow phenomenon presenting with ST segment elevation myocardial infarction.Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy.Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts.
P2860
Q22242896-ED360DD1-E533-4D4E-BBBD-B2D4DEC8A46FQ24187926-39886FD4-C26A-437A-BE3B-A5480B7DB745Q24202298-9A8E9B76-5F28-4431-8A2A-4DFF9FC05F3DQ24234883-1EC5CC28-84FE-4C91-9275-8A678F1BAFBDQ26740252-828CD025-48EF-4BBA-888A-0FF951D75CB1Q26766631-1E31C666-0E70-45B5-87CF-8E3AF8E8C934Q28194262-23FD3B45-2C74-4AEA-856F-A92BE269D7F4Q33578251-BD9E2645-4BCB-4FC4-B5EC-04A4E25FADE6Q33700648-5545CC90-2F93-4572-A724-371EC3EEE89EQ33972619-021B5AB0-44BC-4DA4-B6B8-4D2D50444B2FQ34759513-EB0E8E56-A623-441C-978D-80D51A8C4E94Q35068344-BE1B80B6-68CE-4945-9D15-BE390C49A625Q35158641-B99AD73D-E829-4BBB-A624-C1FFB4D1B891Q35953721-971FAA11-ACDE-4390-8D0B-8570F362F3E8Q36576602-CB662B2B-EE51-4FF0-8FE7-3AB48EF8A3C8Q37152013-1B66FB7F-2CBE-47EA-A164-FD29015A9FA3Q37262612-6139AFD4-4BB1-4302-AFCB-42B2AC1E3150Q37431525-58C9D2D3-AA76-4820-A369-C88F4B349E43Q37779094-97040097-49AA-4026-81AB-096AF5B83990Q37880139-AC21AFD6-FF39-4454-981B-7FCE4C39545BQ38127353-BF3C3EE3-D165-4CA6-A80B-26D424DF1039Q38548146-1F302FA8-6537-4F1B-81E5-D87C497EEEF9Q39330587-5623B002-EE22-49A3-B377-F3D00E3713D5Q39667935-27D6E4A0-7E35-4091-9B84-01215A30271EQ39769940-B7E06A6E-6107-4100-959B-426037CDC928Q40525871-F2EB8583-050A-4BFE-AD0B-B5E9532A9204Q40612721-FD5BF848-41CB-486D-89E3-519970C5D191Q40737970-C5505DF6-DF72-43BD-8E78-81A679A4CD59Q41201201-F8512625-D483-450B-A083-D9C958BCB940Q41674336-F1C55E88-E2BE-4293-95B7-83A0840B322EQ41807571-29EEE618-8421-4698-B121-48A2D276FF5EQ41978657-D9F88F65-AC7D-4436-8D01-E8AFD9825DA8Q42078342-33D8E1D1-E20A-4AEB-A02C-3E7410801B8EQ42830474-BC9C6AF3-A3B1-40F5-8201-72ABB287F1CDQ42833275-177C42F8-6754-4F90-970B-CF11218654B3Q43500579-20E92486-92D8-4E14-8D74-464A2ABFA725Q46770299-417BDB57-C6FC-4151-A1AA-F758BD6AF9FCQ47153037-058E0F65-DDB2-47E9-8506-D3A7528A60F0Q48242903-AAFADD0F-87EE-4306-AF2F-4D81FE210C77Q49404278-5B0B82D1-BFD2-4C75-833E-F915E6BF6111
P2860
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@ast
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@en
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@nl
type
label
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@ast
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@en
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@nl
prefLabel
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@ast
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@en
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@nl
P356
P1476
The coronary no-reflow phenomenon: a review of mechanisms and therapies.
@en
P2093
P304
P356
10.1053/EUHJ.2000.2172
P577
2001-05-01T00:00:00Z